Evidence map›Paper›PMID 33436886›Full record

ArticleScientific reports2021

A selectable, plasmid-based system to generate CRISPR/Cas9 gene edited and knock-in mosquito cell lines.

Kathryn Rozen-Gagnon, Soon Yi, Eliana Jacobson, Sasha Novack, Charles M Rice

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Membrane-localized MET engages PVR to mediate extranuclear juvenile hormone signaling inProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Validation of CRISPR activation system inFrontiers in bioengineering and biotechnology · 2023
    Article
  7. Genome editing.Scientific reports · 2022
    Article
  8. Article
  9. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kathryn Rozen-GagnonLaboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, 10065, USA. krozen@rockefeller.edu.
Soon YiLaboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, 10065, USA.
Eliana JacobsonLaboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, 10065, USA.ORCID http://orcid.org/0000-0001-5360-6223
Sasha NovackLaboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, 10065, USA.
Charles M RiceLaboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, 10065, USA.
Rockefeller University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007250 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI HUANG, ALEX YEE-CHEN · 1985 to 2023
$33.4M
A systematic analysis of small RNA interactions during RNA virus infectionsR01AI116943 · NIAID · ROCKEFELLER UNIVERSITY · PI RICE, CHARLES M · 2016 to 2020
$3.0M
Elucidating the diverse roles of noncoding small RNAs in chikungunya virus infectionF32AI120579 · NIAID · ROCKEFELLER UNIVERSITY · PI ROZEN-GAGNON, KATHRYN · 2015 to 2018
$166k
NIAID NIH HHS F32 AI120579NIAID NIH HHS R01 AI116943NIGMS NIH HHS T32 GM007250
6 · The paper itself

Abstract

Aedes (Ae.) aegypti and Ae. albopictus mosquitoes transmit arthropod-borne diseases around the globe, causing ~ 700,000 deaths each year. Genetic mutants are valuable tools to interrogate both fundamental vector biology and mosquito host factors important for viral infection. However, very few genetic mutants have been described in mosquitoes in comparison to model organisms. The relative ease of applying CRISPR/Cas9-based gene editing has transformed genome engineering and has rapidly increased the number of available gene mutants in mosquitoes. Yet, in vivo studies may not be practical for screening large sets of mutants or possible for laboratories that lack insectaries. Thus, it would be useful to adapt CRISPR/Cas9 systems to common mosquito cell lines. In this study, we generated and characterized a mosquito optimized, plasmid-based CRISPR/Cas9 system for use in U4.4 (Ae. albopictus) and Aag2 (Ae. aegypti) cell lines. We demonstrated highly efficient editing of the AGO1 locus and isolated U4.4 and Aag2 cell lines with reduced AGO1 expression. Further, we used homology-directed repair to establish knock-in Aag2 cell lines with a 3xFLAG-tag at the N-terminus of endogenous AGO1. These experimentally verified plasmids are versatile, cost-effective, and efficiently edit immune competent mosquito cell lines that are widely used in arbovirus studies.

Indexed as

CRISPR-Cas SystemsAedesAnimalsCell LineEukaryotic Initiation FactorsGene EditingGenome, InsectMosquito VectorsPlasmidsEukaryotic Initiation Factors

Identifiers

PMID33436886
PMCPMC7804293
OpenAlexW3120052287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.